StockGlow

Achieve Life Sciences, Inc. (ACHV)

Develops a natural drug to help people quit smoking.

$6.18+0.00%Healthcare
Compare ACHV with
StockGlow Score
92
Bullish
BearishBullish
1 year ago+142.4%

The outlook

ACHV is trading above both its 50- and 200-day moving averages, positioning it in the upper portion of its 52-week range. Analyst consensus is heavily bullish with a Strong Buy rating, and the average price target sits roughly 123% above the current price. The stock shows technical strength, though current price movement is flat.

What’s behind the score

Analyst consensusStrong Buy — 1.2 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range80% of the way from its 52-week low to high
Price targetAvg target +123% vs current price

Analyst price target

~12-month · 10 analysts
$13.80average target+123.3% vs now
Now $6.18
Low $9.00High $21.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$634.4M
52-wk high
$7.11
52-wk low
$2.37
50-day avg
$5.64
200-day avg
$4.71
Trailing P/E
—

Similar stocks

AKTXAkari Therapeutics, Plc$8.43-0.35%XBIOXenetic Biosciences, Inc.$2.50+0.00%DAREDaré Bioscience, Inc.$1.19-10.23%PRPOPrecipio, Inc.$22.67-1.09%ADILAdial Pharmaceuticals, Inc.$2.95+4.98%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy